Show simple item record

dc.contributor.authorHarinasuta, Tranakchiten
dc.contributor.authorBunnag, Danaien
dc.contributor.authorVanijanond, Sen
dc.contributor.authorCharoenlarp, Pen
dc.contributor.authorSuntharasmai, Pen
dc.contributor.authorChitamas, Sen
dc.contributor.authorSheth, U. Ken
dc.contributor.authorWernsdorfer, Walther Hen
dc.date.accessioned2012-06-16T16:02:55Z
dc.date.available2012-06-16T16:02:55Z
dc.date.created1987en
dc.date.issued1987en
dc.identifier.urihttp://www.who.int/iris/handle/10665/48754
dc.subject.meshQuinolinesen
dc.subject.meshSulfadoxineen
dc.subject.meshPyrimethamineen
dc.subject.meshMalariaen
dc.subject.meshPlasmodium falciparumen
dc.subject.meshDrug combinationsen
dc.subject.meshThailanden
dc.subject.otherParasitic Diseases and their Controlen
dc.titleMefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria : a double-blind trial for determining the most effective dose / T. Harinasuta ... [‎et al.]‎en
dc.subject.meshqualifieradministration and dosageen
dc.subject.meshqualifierdrug therapyen
dc.subject.meshqualifierdrug effectsen
dc.relation.ispartofjournalBulletin of the World Health Organization 1985 ; 65(‎3)‎ : 363-367


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record